Levetiracetam thorough QT study: Lack of proarrhythmic effect

被引:0
|
作者
Hulhoven, Reginald [1 ]
Rosillon, D. [1 ]
Bridson, W. [2 ]
Salas, E. [3 ]
Chen, D. [3 ]
Watanabe, S. [1 ]
Meeus, M. A. [1 ]
Stockis, A. [1 ]
机构
[1] UCB Bioprod SA, Braine lAlleud, Belgium
[2] Covance Inc, Clin Res Unit, Madison, WI USA
[3] UCB Inc, Smyma, GA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:361 / 361
页数:1
相关论文
共 50 条
  • [41] The effect of moxifloxacin on QTc and implications for the design of thorough QT studies
    Bloomfield, D. M.
    Kost, J. T.
    Ghosh, K.
    Hreniuk, D.
    Hickey, L. A.
    Guitierrez, M. J.
    Gottesdiener, K.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (04) : 475 - 480
  • [42] Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents
    Frommeyer, Gerrit
    Fischer, Christina
    Ellermann, Christian
    Dechering, Dirk G.
    Kochhaeuser, Simon
    Lange, Philipp S.
    Wasmer, Kristina
    Fehr, Michael
    Eckardt, Lars
    CARDIOVASCULAR TOXICOLOGY, 2018, 18 (01) : 84 - 90
  • [43] Thorough QT StudiesQuestions and Quandaries
    Marek Malik
    Christine E. Garnett
    Joanne Zhang
    Drug Safety, 2010, 33 : 1 - 14
  • [44] The "Thorough QT study": A valid paradigm to test new algorithms for QT interval measurements?
    Badilini, Fabio
    JOURNAL OF ELECTROCARDIOLOGY, 2013, 46 (02) : 126 - 127
  • [46] Sex differences in QT interval variability and implication on sample size of thorough QT study
    Zhang, Lu
    Smith, Brian P.
    DRUG INFORMATION JOURNAL, 2007, 41 (05): : 619 - 627
  • [47] Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents
    Gerrit Frommeyer
    Christina Fischer
    Christian Ellermann
    Dirk G. Dechering
    Simon Kochhäuser
    Philipp S. Lange
    Kristina Wasmer
    Michael Fehr
    Lars Eckardt
    Cardiovascular Toxicology, 2018, 18 : 84 - 90
  • [48] Sex Differences in QT Interval Variability and Implication on Sample Size of Thorough QT Study
    Lu Zhang
    Brian P. Smith
    Drug information journal : DIJ / Drug Information Association, 2007, 41 : 619 - 627
  • [49] Estimation of Proarrhythmic Hazards by QT Prolongation/Shortening: QT Obsession?
    Luc M. Hondeghem
    Drug information journal : DIJ / Drug Information Association, 2006, 40 (3): : 273 - 279
  • [50] Estimation of proarrhythmic hazards by QT prolongation/shortening: QT obsession?
    Hondeghem, Luc M.
    DRUG INFORMATION JOURNAL, 2006, 40 (03): : 273 - 279